| 英文别名 |
Val-Cit-PAB-MMAE;(2R,3R)-N-[(alphaR,betaS)-alpha-Methyl-beta-hydroxyphenethyl]-2-methyl-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-4-[methyl[N-[[4-[(Val-Cit-)amino]benzyloxy]carbonyl]-N-methyl-Val-Val-]amino]-5-methylheptanoyl]pyrrolidine-2-yl]-3-methoxypropionamide;CS-0899246;CS-5780;HY-100374;Val-Cit-PAB-MMAE (GMP);AKOS040744007;EX-A4151;E79123;644981-35-1;N-PM-0008;SCHEMBL12435366;DA-48529;4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate;MS-31988;HY-100374G |
